Literature DB >> 9311807

Human foamy virus reverse transcription that occurs late in the viral replication cycle.

A Moebes1, J Enssle, P D Bieniasz, M Heinkelein, D Lindemann, M Bock, M O McClure, A Rethwilm.   

Abstract

Foamy viruses (FVs) are retroid viruses which use a replication strategy unlike those of other retroviruses and hepadnaviruses (S. F. Yu, D. N. Baldwin, S. R. Gwynn, S. Yendapilli, and M. L. Linial, Science 271:1579-1582, 1996). One of the striking differences between FVs and retroviruses is the presence of large amounts of linear genome-length DNA in FV-infected cells and in virions. We report here that large quantities of genome-length linear FV DNA accumulate in cells infected with FV, as determined by Southern blotting. To determine whether these unintegrated virus DNAs result solely from superinfection, we analyzed the occurrence of virus cDNA of the so-called human FV isolate (HFV) in cells transfected with a virus mutant deficient in the envelope gene and in cells which are resistant to superinfection due to stable expression of the envelope protein. We show that the synthesis of viral cDNA is independent of superinfection and that HFV synthesizes cDNA intracellularly as a late event in the replication cycle. To further confirm this finding, we performed inhibition studies with the reverse transcriptase inhibitor zidovudine (AZT). While AZT had no effect or only a minor effect on virus titers when added to cells prior to virus infection, viral titers were reduced by 3 or 4 orders of magnitude when the virus was produced from cells in the presence of AZT. Our results are most compatible with the hypothesis that the functional nucleic acid of the extracellular HFV consists of largely double-stranded linear DNA.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9311807      PMCID: PMC192074          DOI: 10.1128/JVI.71.10.7305-7311.1997

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  39 in total

Review 1.  Strategies for antiviral therapy in AIDS.

Authors:  H Mitsuya; S Broder
Journal:  Nature       Date:  1987 Feb 26-Mar 4       Impact factor: 49.962

2.  DNA of Rous sarcoma virus: its nature and significance.

Authors:  W E Levinson; H E Varmus; A C Garapin; J M Bishop
Journal:  Science       Date:  1972-01-07       Impact factor: 47.728

3.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 4.  Mechanisms of cell killing/cytopathic effects by nonhuman retroviruses.

Authors:  H M Temin
Journal:  Rev Infect Dis       Date:  1988 Mar-Apr

Review 5.  Form and function of retroviral proviruses.

Authors:  H E Varmus
Journal:  Science       Date:  1982-05-21       Impact factor: 47.728

6.  Establishment of infection by spleen necrosis virus: inhibition in stationary cells and the role of secondary infection.

Authors:  I S Chen; H M Temin
Journal:  J Virol       Date:  1982-01       Impact factor: 5.103

7.  Disease-specific and tissue-specific production of unintegrated feline leukaemia virus variant DNA in feline AIDS.

Authors:  J I Mullins; C S Chen; E A Hoover
Journal:  Nature       Date:  1986 Jan 23-29       Impact factor: 49.962

8.  Efficient pseudotyping of murine leukemia virus particles with chimeric human foamy virus envelope proteins.

Authors:  D Lindemann; M Bock; M Schweizer; A Rethwilm
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

9.  DNA methylation and gene expression: endogenous retroviral genome becomes infectious after molecular cloning.

Authors:  K Harbers; A Schnieke; H Stuhlmann; D Jähner; R Jaenisch
Journal:  Proc Natl Acad Sci U S A       Date:  1981-12       Impact factor: 11.205

10.  Phosphorylation of 3'-azido-3'-deoxythymidine and selective interaction of the 5'-triphosphate with human immunodeficiency virus reverse transcriptase.

Authors:  P A Furman; J A Fyfe; M H St Clair; K Weinhold; J L Rideout; G A Freeman; S N Lehrman; D P Bolognesi; S Broder; H Mitsuya
Journal:  Proc Natl Acad Sci U S A       Date:  1986-11       Impact factor: 11.205

View more
  97 in total

1.  Complex effects of deletions in the 5' untranslated region of primate foamy virus on viral gene expression and RNA packaging.

Authors:  M Heinkelein; J Thurow; M Dressler; H Imrich; D Neumann-Haefelin; M O McClure; A Rethwilm
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Differential sensitivities of retroviruses to integrase strand transfer inhibitors.

Authors:  Yasuhiro Koh; Kenneth A Matreyek; Alan Engelman
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

3.  Transduction of human NOD/SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors.

Authors:  Neil C Josephson; George Vassilopoulos; Grant D Trobridge; Greg V Priestley; Brent L Wood; Thalia Papayannopoulou; David W Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-06-11       Impact factor: 11.205

4.  Biphasic DNA synthesis in spumaviruses.

Authors:  Olivier Delelis; Ali Saïb; Pierre Sonigo
Journal:  J Virol       Date:  2003-07       Impact factor: 5.103

5.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

Review 6.  Molecular biology of foamy viruses.

Authors:  Axel Rethwilm
Journal:  Med Microbiol Immunol       Date:  2010-05-06       Impact factor: 3.402

7.  Nonintegrating foamy virus vectors.

Authors:  David R Deyle; Yi Li; Erik M Olson; David W Russell
Journal:  J Virol       Date:  2010-06-30       Impact factor: 5.103

8.  Novel functions of prototype foamy virus Gag glycine- arginine-rich boxes in reverse transcription and particle morphogenesis.

Authors:  Erik Müllers; Tobias Uhlig; Kristin Stirnnagel; Uwe Fiebig; Hanswalter Zentgraf; Dirk Lindemann
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

9.  Identification of domains in gag important for prototypic foamy virus egress.

Authors:  Gillian S Patton; Stephen A Morris; Wayne Chung; Paul D Bieniasz; Myra O McClure
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

10.  Efficient transient genetic manipulation in vitro and in vivo by prototype foamy virus-mediated nonviral RNA transfer.

Authors:  Martin V Hamann; Nicole Stanke; Erik Müllers; Kristin Stirnnagel; Sylvia Hütter; Benedetta Artegiani; Sara Bragado Alonso; Federico Calegari; Dirk Lindemann
Journal:  Mol Ther       Date:  2014-05-12       Impact factor: 11.454

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.